Literature DB >> 10571205

A point mutation of human p53, which was not detected as a mutation by a yeast functional assay, led to apoptosis but not p21Waf1/Cip1/Sdi1 expression in response to ionizing radiation in a human osteosarcoma cell line, Saos-2.

K Okaichi1, L H Wang, J Sasaki, H Saya, M Tada, Y Okumura.   

Abstract

PURPOSE: The 123A point mutation of p53 showed increased radiosensitivity, whereas other mutations (143A, 175H, and 273H) were not affected. To determine the reason for increased radiosensitivity of the 123A mutation, the response of the transformant of 123A mutation to ionizing radiation (IR) was examined and compared to those of transformants with the wild type p53 or other point mutations (143A, 175H, and 273H). METHODS AND MATERIALS: Stable transformants with a mutant or wild type p53 made by introducing cDNA into the human osteosarcoma cell line, Saos-2, which lacks an endogenous p53 were used. The transcriptional activity of mutant p53 was examined using a yeast functional assay. The transformants were examined for the accumulation of p53, the induction of p21Waf1/Cip1/Sdi1 (hereafter referred to as p21), and the other response of p53-responsive genes (MDM2, Bax, and Bcl-2) by Western blotting. Apoptosis was analyzed by detection of DNA fragmentation.
RESULTS: The 123A point mutation of p53 was detected as a wild type in the yeast functional assay. The 123A mutant accumulated p53 in response to IR. The 123A mutant did not induce p21, but normally responded to MDM2, Bax, and Bcl-2. The 123A mutant entered apoptosis earlier than the wild type p53 transformant, and induced Fas at earlier in response to IR.
CONCLUSION: The 123A mutant led to apoptosis, but not p21 expression in response to IR. The occurrence of apoptosis, but not induction of p21, corresponded to the radiosensitivity in the transformant. The early occurrence of apoptosis in 123A transformants may depend on the early induction of Fas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571205     DOI: 10.1016/s0360-3016(99)00285-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

Review 1.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

2.  The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis.

Authors:  Guanghui Cheng; Dejuan Kong; Xue Hou; Bing Liang; Mengzi He; Nan Liang; Shumei Ma; Xiaodong Liu
Journal:  Cancer Biother Radiopharm       Date:  2012-12-26       Impact factor: 3.099

3.  PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines.

Authors:  Patricia Izetti; Agnes Hautefeuille; Ana Lucia Abujamra; Caroline Brunetto de Farias; Juliana Giacomazzi; Bárbara Alemar; Guido Lenz; Rafael Roesler; Gilberto Schwartsmann; Alessandro Bersch Osvaldt; Pierre Hainaut; Patricia Ashton-Prolla
Journal:  Invest New Drugs       Date:  2014-05-20       Impact factor: 3.850

4.  Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

Authors:  Mohd Saif Zaman; Varahram Shahryari; Guoren Deng; Sobha Thamminana; Sharonjot Saini; Shahana Majid; Inik Chang; Hiroshi Hirata; Koji Ueno; Soichiro Yamamura; Kamaldeep Singh; Yuichiro Tanaka; Z Laura Tabatabai; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

5.  Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model.

Authors:  Jian Pei; In-Ho Park; Hyang-Hwa Ryu; Song-Yuan Li; Chun-Hao Li; Sa-Hoe Lim; Min Wen; Woo-Youl Jang; Shin Jung
Journal:  Radiat Oncol       Date:  2015-08-06       Impact factor: 3.481

6.  Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma.

Authors:  Mingbin Zhang; Jiang Li; Lizhen Wang; Zhen Tian; Ping Zhang; Qin Xu; Chenping Zhang; Fengcai Wei; Wantao Chen
Journal:  Oncol Lett       Date:  2013-06-07       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.